Medical Care
Global Alpha Particle Targeted Therapy Market Research Report 2026
- Mar 17, 26
- ID: 734749
- Pages: 111
- Figures: 117
- Views: 19
This report delivers a comprehensive overview of the global Alpha Particle Targeted Therapy market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Alpha Particle Targeted Therapy. The Alpha Particle Targeted Therapy market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Alpha Particle Targeted Therapy market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Alpha Particle Targeted Therapy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Fusion Pharma
Bayer
Roche
Novartis
Orano Med
Oncoinvent AS
Perspective Therapeutics
Ablaze Pharma
ARTBIO
AstraZeneca
AdvanCell
Segment by Type
Antibodies
Peptides or Small Molecules
Segment by Application
Basic Radiochemistry
Clinical Research
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Alpha Particle Targeted Therapy companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
The report segments the global Alpha Particle Targeted Therapy market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Alpha Particle Targeted Therapy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Fusion Pharma
Bayer
Roche
Novartis
Orano Med
Oncoinvent AS
Perspective Therapeutics
Ablaze Pharma
ARTBIO
AstraZeneca
AdvanCell
Segment by Type
Antibodies
Peptides or Small Molecules
Segment by Application
Basic Radiochemistry
Clinical Research
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Alpha Particle Targeted Therapy companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alpha Particle Targeted Therapy Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Antibodies
1.2.3 Peptides or Small Molecules
1.3 Market by Application
1.3.1 Global Alpha Particle Targeted Therapy Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Basic Radiochemistry
1.3.3 Clinical Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Alpha Particle Targeted Therapy Market Perspective (2021–2032)
2.2 Global Alpha Particle Targeted Therapy Growth Trends by Region
2.2.1 Global Alpha Particle Targeted Therapy Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Alpha Particle Targeted Therapy Historic Market Size by Region (2021–2026)
2.2.3 Alpha Particle Targeted Therapy Forecasted Market Size by Region (2027–2032)
2.3 Alpha Particle Targeted Therapy Market Dynamics
2.3.1 Alpha Particle Targeted Therapy Industry Trends
2.3.2 Alpha Particle Targeted Therapy Market Drivers
2.3.3 Alpha Particle Targeted Therapy Market Challenges
2.3.4 Alpha Particle Targeted Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alpha Particle Targeted Therapy Players by Revenue
3.1.1 Global Top Alpha Particle Targeted Therapy Players by Revenue (2021–2026)
3.1.2 Global Alpha Particle Targeted Therapy Revenue Market Share by Players (2021–2026)
3.2 Global Top Alpha Particle Targeted Therapy Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Alpha Particle Targeted Therapy Revenue
3.4 Global Alpha Particle Targeted Therapy Market Concentration Ratio
3.4.1 Global Alpha Particle Targeted Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alpha Particle Targeted Therapy Revenue in 2025
3.5 Global Key Players of Alpha Particle Targeted Therapy Head Offices and Areas Served
3.6 Global Key Players of Alpha Particle Targeted Therapy, Products and Applications
3.7 Global Key Players of Alpha Particle Targeted Therapy, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Alpha Particle Targeted Therapy Breakdown Data by Type
4.1 Global Alpha Particle Targeted Therapy Historic Market Size by Type (2021–2026)
4.2 Global Alpha Particle Targeted Therapy Forecasted Market Size by Type (2027–2032)
5 Alpha Particle Targeted Therapy Breakdown Data by Application
5.1 Global Alpha Particle Targeted Therapy Historic Market Size by Application (2021–2026)
5.2 Global Alpha Particle Targeted Therapy Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Alpha Particle Targeted Therapy Market Size (2021–2032)
6.2 North America Alpha Particle Targeted Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Alpha Particle Targeted Therapy Market Size by Country (2021–2026)
6.4 North America Alpha Particle Targeted Therapy Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Alpha Particle Targeted Therapy Market Size (2021–2032)
7.2 Europe Alpha Particle Targeted Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Alpha Particle Targeted Therapy Market Size by Country (2021–2026)
7.4 Europe Alpha Particle Targeted Therapy Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Alpha Particle Targeted Therapy Market Size (2021–2032)
8.2 Asia-Pacific Alpha Particle Targeted Therapy Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Alpha Particle Targeted Therapy Market Size by Region (2021–2026)
8.4 Asia-Pacific Alpha Particle Targeted Therapy Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Alpha Particle Targeted Therapy Market Size (2021–2032)
9.2 Latin America Alpha Particle Targeted Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Alpha Particle Targeted Therapy Market Size by Country (2021–2026)
9.4 Latin America Alpha Particle Targeted Therapy Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alpha Particle Targeted Therapy Market Size (2021–2032)
10.2 Middle East & Africa Alpha Particle Targeted Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Alpha Particle Targeted Therapy Market Size by Country (2021–2026)
10.4 Middle East & Africa Alpha Particle Targeted Therapy Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Fusion Pharma
11.1.1 Fusion Pharma Company Details
11.1.2 Fusion Pharma Business Overview
11.1.3 Fusion Pharma Alpha Particle Targeted Therapy Introduction
11.1.4 Fusion Pharma Revenue in Alpha Particle Targeted Therapy Business (2021–2026)
11.1.5 Fusion Pharma Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Alpha Particle Targeted Therapy Introduction
11.2.4 Bayer Revenue in Alpha Particle Targeted Therapy Business (2021–2026)
11.2.5 Bayer Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Alpha Particle Targeted Therapy Introduction
11.3.4 Roche Revenue in Alpha Particle Targeted Therapy Business (2021–2026)
11.3.5 Roche Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Alpha Particle Targeted Therapy Introduction
11.4.4 Novartis Revenue in Alpha Particle Targeted Therapy Business (2021–2026)
11.4.5 Novartis Recent Development
11.5 Orano Med
11.5.1 Orano Med Company Details
11.5.2 Orano Med Business Overview
11.5.3 Orano Med Alpha Particle Targeted Therapy Introduction
11.5.4 Orano Med Revenue in Alpha Particle Targeted Therapy Business (2021–2026)
11.5.5 Orano Med Recent Development
11.6 Oncoinvent AS
11.6.1 Oncoinvent AS Company Details
11.6.2 Oncoinvent AS Business Overview
11.6.3 Oncoinvent AS Alpha Particle Targeted Therapy Introduction
11.6.4 Oncoinvent AS Revenue in Alpha Particle Targeted Therapy Business (2021–2026)
11.6.5 Oncoinvent AS Recent Development
11.7 Perspective Therapeutics
11.7.1 Perspective Therapeutics Company Details
11.7.2 Perspective Therapeutics Business Overview
11.7.3 Perspective Therapeutics Alpha Particle Targeted Therapy Introduction
11.7.4 Perspective Therapeutics Revenue in Alpha Particle Targeted Therapy Business (2021–2026)
11.7.5 Perspective Therapeutics Recent Development
11.8 Ablaze Pharma
11.8.1 Ablaze Pharma Company Details
11.8.2 Ablaze Pharma Business Overview
11.8.3 Ablaze Pharma Alpha Particle Targeted Therapy Introduction
11.8.4 Ablaze Pharma Revenue in Alpha Particle Targeted Therapy Business (2021–2026)
11.8.5 Ablaze Pharma Recent Development
11.9 ARTBIO
11.9.1 ARTBIO Company Details
11.9.2 ARTBIO Business Overview
11.9.3 ARTBIO Alpha Particle Targeted Therapy Introduction
11.9.4 ARTBIO Revenue in Alpha Particle Targeted Therapy Business (2021–2026)
11.9.5 ARTBIO Recent Development
11.10 AstraZeneca
11.10.1 AstraZeneca Company Details
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca Alpha Particle Targeted Therapy Introduction
11.10.4 AstraZeneca Revenue in Alpha Particle Targeted Therapy Business (2021–2026)
11.10.5 AstraZeneca Recent Development
11.11 AdvanCell
11.11.1 AdvanCell Company Details
11.11.2 AdvanCell Business Overview
11.11.3 AdvanCell Alpha Particle Targeted Therapy Introduction
11.11.4 AdvanCell Revenue in Alpha Particle Targeted Therapy Business (2021–2026)
11.11.5 AdvanCell Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alpha Particle Targeted Therapy Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Antibodies
1.2.3 Peptides or Small Molecules
1.3 Market by Application
1.3.1 Global Alpha Particle Targeted Therapy Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Basic Radiochemistry
1.3.3 Clinical Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Alpha Particle Targeted Therapy Market Perspective (2021–2032)
2.2 Global Alpha Particle Targeted Therapy Growth Trends by Region
2.2.1 Global Alpha Particle Targeted Therapy Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Alpha Particle Targeted Therapy Historic Market Size by Region (2021–2026)
2.2.3 Alpha Particle Targeted Therapy Forecasted Market Size by Region (2027–2032)
2.3 Alpha Particle Targeted Therapy Market Dynamics
2.3.1 Alpha Particle Targeted Therapy Industry Trends
2.3.2 Alpha Particle Targeted Therapy Market Drivers
2.3.3 Alpha Particle Targeted Therapy Market Challenges
2.3.4 Alpha Particle Targeted Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alpha Particle Targeted Therapy Players by Revenue
3.1.1 Global Top Alpha Particle Targeted Therapy Players by Revenue (2021–2026)
3.1.2 Global Alpha Particle Targeted Therapy Revenue Market Share by Players (2021–2026)
3.2 Global Top Alpha Particle Targeted Therapy Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Alpha Particle Targeted Therapy Revenue
3.4 Global Alpha Particle Targeted Therapy Market Concentration Ratio
3.4.1 Global Alpha Particle Targeted Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alpha Particle Targeted Therapy Revenue in 2025
3.5 Global Key Players of Alpha Particle Targeted Therapy Head Offices and Areas Served
3.6 Global Key Players of Alpha Particle Targeted Therapy, Products and Applications
3.7 Global Key Players of Alpha Particle Targeted Therapy, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Alpha Particle Targeted Therapy Breakdown Data by Type
4.1 Global Alpha Particle Targeted Therapy Historic Market Size by Type (2021–2026)
4.2 Global Alpha Particle Targeted Therapy Forecasted Market Size by Type (2027–2032)
5 Alpha Particle Targeted Therapy Breakdown Data by Application
5.1 Global Alpha Particle Targeted Therapy Historic Market Size by Application (2021–2026)
5.2 Global Alpha Particle Targeted Therapy Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Alpha Particle Targeted Therapy Market Size (2021–2032)
6.2 North America Alpha Particle Targeted Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Alpha Particle Targeted Therapy Market Size by Country (2021–2026)
6.4 North America Alpha Particle Targeted Therapy Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Alpha Particle Targeted Therapy Market Size (2021–2032)
7.2 Europe Alpha Particle Targeted Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Alpha Particle Targeted Therapy Market Size by Country (2021–2026)
7.4 Europe Alpha Particle Targeted Therapy Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Alpha Particle Targeted Therapy Market Size (2021–2032)
8.2 Asia-Pacific Alpha Particle Targeted Therapy Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Alpha Particle Targeted Therapy Market Size by Region (2021–2026)
8.4 Asia-Pacific Alpha Particle Targeted Therapy Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Alpha Particle Targeted Therapy Market Size (2021–2032)
9.2 Latin America Alpha Particle Targeted Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Alpha Particle Targeted Therapy Market Size by Country (2021–2026)
9.4 Latin America Alpha Particle Targeted Therapy Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alpha Particle Targeted Therapy Market Size (2021–2032)
10.2 Middle East & Africa Alpha Particle Targeted Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Alpha Particle Targeted Therapy Market Size by Country (2021–2026)
10.4 Middle East & Africa Alpha Particle Targeted Therapy Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Fusion Pharma
11.1.1 Fusion Pharma Company Details
11.1.2 Fusion Pharma Business Overview
11.1.3 Fusion Pharma Alpha Particle Targeted Therapy Introduction
11.1.4 Fusion Pharma Revenue in Alpha Particle Targeted Therapy Business (2021–2026)
11.1.5 Fusion Pharma Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Alpha Particle Targeted Therapy Introduction
11.2.4 Bayer Revenue in Alpha Particle Targeted Therapy Business (2021–2026)
11.2.5 Bayer Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Alpha Particle Targeted Therapy Introduction
11.3.4 Roche Revenue in Alpha Particle Targeted Therapy Business (2021–2026)
11.3.5 Roche Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Alpha Particle Targeted Therapy Introduction
11.4.4 Novartis Revenue in Alpha Particle Targeted Therapy Business (2021–2026)
11.4.5 Novartis Recent Development
11.5 Orano Med
11.5.1 Orano Med Company Details
11.5.2 Orano Med Business Overview
11.5.3 Orano Med Alpha Particle Targeted Therapy Introduction
11.5.4 Orano Med Revenue in Alpha Particle Targeted Therapy Business (2021–2026)
11.5.5 Orano Med Recent Development
11.6 Oncoinvent AS
11.6.1 Oncoinvent AS Company Details
11.6.2 Oncoinvent AS Business Overview
11.6.3 Oncoinvent AS Alpha Particle Targeted Therapy Introduction
11.6.4 Oncoinvent AS Revenue in Alpha Particle Targeted Therapy Business (2021–2026)
11.6.5 Oncoinvent AS Recent Development
11.7 Perspective Therapeutics
11.7.1 Perspective Therapeutics Company Details
11.7.2 Perspective Therapeutics Business Overview
11.7.3 Perspective Therapeutics Alpha Particle Targeted Therapy Introduction
11.7.4 Perspective Therapeutics Revenue in Alpha Particle Targeted Therapy Business (2021–2026)
11.7.5 Perspective Therapeutics Recent Development
11.8 Ablaze Pharma
11.8.1 Ablaze Pharma Company Details
11.8.2 Ablaze Pharma Business Overview
11.8.3 Ablaze Pharma Alpha Particle Targeted Therapy Introduction
11.8.4 Ablaze Pharma Revenue in Alpha Particle Targeted Therapy Business (2021–2026)
11.8.5 Ablaze Pharma Recent Development
11.9 ARTBIO
11.9.1 ARTBIO Company Details
11.9.2 ARTBIO Business Overview
11.9.3 ARTBIO Alpha Particle Targeted Therapy Introduction
11.9.4 ARTBIO Revenue in Alpha Particle Targeted Therapy Business (2021–2026)
11.9.5 ARTBIO Recent Development
11.10 AstraZeneca
11.10.1 AstraZeneca Company Details
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca Alpha Particle Targeted Therapy Introduction
11.10.4 AstraZeneca Revenue in Alpha Particle Targeted Therapy Business (2021–2026)
11.10.5 AstraZeneca Recent Development
11.11 AdvanCell
11.11.1 AdvanCell Company Details
11.11.2 AdvanCell Business Overview
11.11.3 AdvanCell Alpha Particle Targeted Therapy Introduction
11.11.4 AdvanCell Revenue in Alpha Particle Targeted Therapy Business (2021–2026)
11.11.5 AdvanCell Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Alpha Particle Targeted Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Antibodies
Table 3. Key Players of Peptides or Small Molecules
Table 4. Global Alpha Particle Targeted Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Alpha Particle Targeted Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Alpha Particle Targeted Therapy Market Size by Region (US$ Million), 2021–2026
Table 7. Global Alpha Particle Targeted Therapy Market Share by Region (2021–2026)
Table 8. Global Alpha Particle Targeted Therapy Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Alpha Particle Targeted Therapy Market Share by Region (2027–2032)
Table 10. Alpha Particle Targeted Therapy Market Trends
Table 11. Alpha Particle Targeted Therapy Market Drivers
Table 12. Alpha Particle Targeted Therapy Market Challenges
Table 13. Alpha Particle Targeted Therapy Market Restraints
Table 14. Global Alpha Particle Targeted Therapy Revenue by Players (US$ Million), 2021–2026
Table 15. Global Alpha Particle Targeted Therapy Market Share by Players (2021–2026)
Table 16. Global Top Alpha Particle Targeted Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on Alpha Particle Targeted Therapy Revenue, 2025
Table 17. Ranking of Global Top Alpha Particle Targeted Therapy Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Alpha Particle Targeted Therapy Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Alpha Particle Targeted Therapy, Headquarters and Area Served
Table 20. Global Key Players of Alpha Particle Targeted Therapy, Products and Applications
Table 21. Global Key Players of Alpha Particle Targeted Therapy, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Alpha Particle Targeted Therapy Market Size by Type (US$ Million), 2021–2026
Table 24. Global Alpha Particle Targeted Therapy Revenue Market Share by Type (2021–2026)
Table 25. Global Alpha Particle Targeted Therapy Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Alpha Particle Targeted Therapy Revenue Market Share by Type (2027–2032)
Table 27. Global Alpha Particle Targeted Therapy Market Size by Application (US$ Million), 2021–2026
Table 28. Global Alpha Particle Targeted Therapy Revenue Market Share by Application (2021–2026)
Table 29. Global Alpha Particle Targeted Therapy Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Alpha Particle Targeted Therapy Revenue Market Share by Application (2027–2032)
Table 31. North America Alpha Particle Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Alpha Particle Targeted Therapy Market Size by Country (US$ Million), 2021–2026
Table 33. North America Alpha Particle Targeted Therapy Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Alpha Particle Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Alpha Particle Targeted Therapy Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Alpha Particle Targeted Therapy Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Alpha Particle Targeted Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Alpha Particle Targeted Therapy Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Alpha Particle Targeted Therapy Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Alpha Particle Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Alpha Particle Targeted Therapy Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Alpha Particle Targeted Therapy Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Alpha Particle Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Alpha Particle Targeted Therapy Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Alpha Particle Targeted Therapy Market Size by Country (US$ Million), 2027–2032
Table 46. Fusion Pharma Company Details
Table 47. Fusion Pharma Business Overview
Table 48. Fusion Pharma Alpha Particle Targeted Therapy Product
Table 49. Fusion Pharma Revenue in Alpha Particle Targeted Therapy Business (US$ Million), 2021–2026
Table 50. Fusion Pharma Recent Development
Table 51. Bayer Company Details
Table 52. Bayer Business Overview
Table 53. Bayer Alpha Particle Targeted Therapy Product
Table 54. Bayer Revenue in Alpha Particle Targeted Therapy Business (US$ Million), 2021–2026
Table 55. Bayer Recent Development
Table 56. Roche Company Details
Table 57. Roche Business Overview
Table 58. Roche Alpha Particle Targeted Therapy Product
Table 59. Roche Revenue in Alpha Particle Targeted Therapy Business (US$ Million), 2021–2026
Table 60. Roche Recent Development
Table 61. Novartis Company Details
Table 62. Novartis Business Overview
Table 63. Novartis Alpha Particle Targeted Therapy Product
Table 64. Novartis Revenue in Alpha Particle Targeted Therapy Business (US$ Million), 2021–2026
Table 65. Novartis Recent Development
Table 66. Orano Med Company Details
Table 67. Orano Med Business Overview
Table 68. Orano Med Alpha Particle Targeted Therapy Product
Table 69. Orano Med Revenue in Alpha Particle Targeted Therapy Business (US$ Million), 2021–2026
Table 70. Orano Med Recent Development
Table 71. Oncoinvent AS Company Details
Table 72. Oncoinvent AS Business Overview
Table 73. Oncoinvent AS Alpha Particle Targeted Therapy Product
Table 74. Oncoinvent AS Revenue in Alpha Particle Targeted Therapy Business (US$ Million), 2021–2026
Table 75. Oncoinvent AS Recent Development
Table 76. Perspective Therapeutics Company Details
Table 77. Perspective Therapeutics Business Overview
Table 78. Perspective Therapeutics Alpha Particle Targeted Therapy Product
Table 79. Perspective Therapeutics Revenue in Alpha Particle Targeted Therapy Business (US$ Million), 2021–2026
Table 80. Perspective Therapeutics Recent Development
Table 81. Ablaze Pharma Company Details
Table 82. Ablaze Pharma Business Overview
Table 83. Ablaze Pharma Alpha Particle Targeted Therapy Product
Table 84. Ablaze Pharma Revenue in Alpha Particle Targeted Therapy Business (US$ Million), 2021–2026
Table 85. Ablaze Pharma Recent Development
Table 86. ARTBIO Company Details
Table 87. ARTBIO Business Overview
Table 88. ARTBIO Alpha Particle Targeted Therapy Product
Table 89. ARTBIO Revenue in Alpha Particle Targeted Therapy Business (US$ Million), 2021–2026
Table 90. ARTBIO Recent Development
Table 91. AstraZeneca Company Details
Table 92. AstraZeneca Business Overview
Table 93. AstraZeneca Alpha Particle Targeted Therapy Product
Table 94. AstraZeneca Revenue in Alpha Particle Targeted Therapy Business (US$ Million), 2021–2026
Table 95. AstraZeneca Recent Development
Table 96. AdvanCell Company Details
Table 97. AdvanCell Business Overview
Table 98. AdvanCell Alpha Particle Targeted Therapy Product
Table 99. AdvanCell Revenue in Alpha Particle Targeted Therapy Business (US$ Million), 2021–2026
Table 100. AdvanCell Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
Table 104. Authors List of This Report
List of Figures
Figure 1. Alpha Particle Targeted Therapy Picture
Figure 2. Global Alpha Particle Targeted Therapy Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Alpha Particle Targeted Therapy Market Share by Type: 2025 vs 2032
Figure 4. Antibodies Features
Figure 5. Peptides or Small Molecules Features
Figure 6. Global Alpha Particle Targeted Therapy Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Alpha Particle Targeted Therapy Market Share by Application: 2025 vs 2032
Figure 8. Basic Radiochemistry Case Studies
Figure 9. Clinical Research Case Studies
Figure 10. Alpha Particle Targeted Therapy Report Years Considered
Figure 11. Global Alpha Particle Targeted Therapy Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 12. Global Alpha Particle Targeted Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Alpha Particle Targeted Therapy Market Share by Region: 2025 vs 2032
Figure 14. Global Alpha Particle Targeted Therapy Market Share by Players in 2025
Figure 15. Global Alpha Particle Targeted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 16. The Top 10 and 5 Players Market Share by Alpha Particle Targeted Therapy Revenue in 2025
Figure 17. North America Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 18. North America Alpha Particle Targeted Therapy Market Share by Country (2021–2032)
Figure 19. United States Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. Canada Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Europe Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Alpha Particle Targeted Therapy Market Share by Country (2021–2032)
Figure 23. Germany Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. France Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. U.K. Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Italy Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Russia Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Ireland Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Asia-Pacific Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Alpha Particle Targeted Therapy Market Share by Region (2021–2032)
Figure 31. China Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Japan Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. South Korea Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Southeast Asia Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. India Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Australia & New Zealand Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Latin America Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Alpha Particle Targeted Therapy Market Share by Country (2021–2032)
Figure 39. Mexico Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Brazil Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Middle East & Africa Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Alpha Particle Targeted Therapy Market Share by Country (2021–2032)
Figure 43. Israel Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Saudi Arabia Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. UAE Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Fusion Pharma Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2021–2026)
Figure 47. Bayer Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2021–2026)
Figure 48. Roche Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2021–2026)
Figure 49. Novartis Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2021–2026)
Figure 50. Orano Med Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2021–2026)
Figure 51. Oncoinvent AS Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2021–2026)
Figure 52. Perspective Therapeutics Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2021–2026)
Figure 53. Ablaze Pharma Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2021–2026)
Figure 54. ARTBIO Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2021–2026)
Figure 55. AstraZeneca Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2021–2026)
Figure 56. AdvanCell Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2021–2026)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Table 1. Global Alpha Particle Targeted Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Antibodies
Table 3. Key Players of Peptides or Small Molecules
Table 4. Global Alpha Particle Targeted Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Alpha Particle Targeted Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Alpha Particle Targeted Therapy Market Size by Region (US$ Million), 2021–2026
Table 7. Global Alpha Particle Targeted Therapy Market Share by Region (2021–2026)
Table 8. Global Alpha Particle Targeted Therapy Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Alpha Particle Targeted Therapy Market Share by Region (2027–2032)
Table 10. Alpha Particle Targeted Therapy Market Trends
Table 11. Alpha Particle Targeted Therapy Market Drivers
Table 12. Alpha Particle Targeted Therapy Market Challenges
Table 13. Alpha Particle Targeted Therapy Market Restraints
Table 14. Global Alpha Particle Targeted Therapy Revenue by Players (US$ Million), 2021–2026
Table 15. Global Alpha Particle Targeted Therapy Market Share by Players (2021–2026)
Table 16. Global Top Alpha Particle Targeted Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on Alpha Particle Targeted Therapy Revenue, 2025
Table 17. Ranking of Global Top Alpha Particle Targeted Therapy Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Alpha Particle Targeted Therapy Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Alpha Particle Targeted Therapy, Headquarters and Area Served
Table 20. Global Key Players of Alpha Particle Targeted Therapy, Products and Applications
Table 21. Global Key Players of Alpha Particle Targeted Therapy, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Alpha Particle Targeted Therapy Market Size by Type (US$ Million), 2021–2026
Table 24. Global Alpha Particle Targeted Therapy Revenue Market Share by Type (2021–2026)
Table 25. Global Alpha Particle Targeted Therapy Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Alpha Particle Targeted Therapy Revenue Market Share by Type (2027–2032)
Table 27. Global Alpha Particle Targeted Therapy Market Size by Application (US$ Million), 2021–2026
Table 28. Global Alpha Particle Targeted Therapy Revenue Market Share by Application (2021–2026)
Table 29. Global Alpha Particle Targeted Therapy Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Alpha Particle Targeted Therapy Revenue Market Share by Application (2027–2032)
Table 31. North America Alpha Particle Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Alpha Particle Targeted Therapy Market Size by Country (US$ Million), 2021–2026
Table 33. North America Alpha Particle Targeted Therapy Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Alpha Particle Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Alpha Particle Targeted Therapy Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Alpha Particle Targeted Therapy Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Alpha Particle Targeted Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Alpha Particle Targeted Therapy Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Alpha Particle Targeted Therapy Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Alpha Particle Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Alpha Particle Targeted Therapy Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Alpha Particle Targeted Therapy Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Alpha Particle Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Alpha Particle Targeted Therapy Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Alpha Particle Targeted Therapy Market Size by Country (US$ Million), 2027–2032
Table 46. Fusion Pharma Company Details
Table 47. Fusion Pharma Business Overview
Table 48. Fusion Pharma Alpha Particle Targeted Therapy Product
Table 49. Fusion Pharma Revenue in Alpha Particle Targeted Therapy Business (US$ Million), 2021–2026
Table 50. Fusion Pharma Recent Development
Table 51. Bayer Company Details
Table 52. Bayer Business Overview
Table 53. Bayer Alpha Particle Targeted Therapy Product
Table 54. Bayer Revenue in Alpha Particle Targeted Therapy Business (US$ Million), 2021–2026
Table 55. Bayer Recent Development
Table 56. Roche Company Details
Table 57. Roche Business Overview
Table 58. Roche Alpha Particle Targeted Therapy Product
Table 59. Roche Revenue in Alpha Particle Targeted Therapy Business (US$ Million), 2021–2026
Table 60. Roche Recent Development
Table 61. Novartis Company Details
Table 62. Novartis Business Overview
Table 63. Novartis Alpha Particle Targeted Therapy Product
Table 64. Novartis Revenue in Alpha Particle Targeted Therapy Business (US$ Million), 2021–2026
Table 65. Novartis Recent Development
Table 66. Orano Med Company Details
Table 67. Orano Med Business Overview
Table 68. Orano Med Alpha Particle Targeted Therapy Product
Table 69. Orano Med Revenue in Alpha Particle Targeted Therapy Business (US$ Million), 2021–2026
Table 70. Orano Med Recent Development
Table 71. Oncoinvent AS Company Details
Table 72. Oncoinvent AS Business Overview
Table 73. Oncoinvent AS Alpha Particle Targeted Therapy Product
Table 74. Oncoinvent AS Revenue in Alpha Particle Targeted Therapy Business (US$ Million), 2021–2026
Table 75. Oncoinvent AS Recent Development
Table 76. Perspective Therapeutics Company Details
Table 77. Perspective Therapeutics Business Overview
Table 78. Perspective Therapeutics Alpha Particle Targeted Therapy Product
Table 79. Perspective Therapeutics Revenue in Alpha Particle Targeted Therapy Business (US$ Million), 2021–2026
Table 80. Perspective Therapeutics Recent Development
Table 81. Ablaze Pharma Company Details
Table 82. Ablaze Pharma Business Overview
Table 83. Ablaze Pharma Alpha Particle Targeted Therapy Product
Table 84. Ablaze Pharma Revenue in Alpha Particle Targeted Therapy Business (US$ Million), 2021–2026
Table 85. Ablaze Pharma Recent Development
Table 86. ARTBIO Company Details
Table 87. ARTBIO Business Overview
Table 88. ARTBIO Alpha Particle Targeted Therapy Product
Table 89. ARTBIO Revenue in Alpha Particle Targeted Therapy Business (US$ Million), 2021–2026
Table 90. ARTBIO Recent Development
Table 91. AstraZeneca Company Details
Table 92. AstraZeneca Business Overview
Table 93. AstraZeneca Alpha Particle Targeted Therapy Product
Table 94. AstraZeneca Revenue in Alpha Particle Targeted Therapy Business (US$ Million), 2021–2026
Table 95. AstraZeneca Recent Development
Table 96. AdvanCell Company Details
Table 97. AdvanCell Business Overview
Table 98. AdvanCell Alpha Particle Targeted Therapy Product
Table 99. AdvanCell Revenue in Alpha Particle Targeted Therapy Business (US$ Million), 2021–2026
Table 100. AdvanCell Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
Table 104. Authors List of This Report
List of Figures
Figure 1. Alpha Particle Targeted Therapy Picture
Figure 2. Global Alpha Particle Targeted Therapy Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Alpha Particle Targeted Therapy Market Share by Type: 2025 vs 2032
Figure 4. Antibodies Features
Figure 5. Peptides or Small Molecules Features
Figure 6. Global Alpha Particle Targeted Therapy Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Alpha Particle Targeted Therapy Market Share by Application: 2025 vs 2032
Figure 8. Basic Radiochemistry Case Studies
Figure 9. Clinical Research Case Studies
Figure 10. Alpha Particle Targeted Therapy Report Years Considered
Figure 11. Global Alpha Particle Targeted Therapy Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 12. Global Alpha Particle Targeted Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Alpha Particle Targeted Therapy Market Share by Region: 2025 vs 2032
Figure 14. Global Alpha Particle Targeted Therapy Market Share by Players in 2025
Figure 15. Global Alpha Particle Targeted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 16. The Top 10 and 5 Players Market Share by Alpha Particle Targeted Therapy Revenue in 2025
Figure 17. North America Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 18. North America Alpha Particle Targeted Therapy Market Share by Country (2021–2032)
Figure 19. United States Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. Canada Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Europe Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Alpha Particle Targeted Therapy Market Share by Country (2021–2032)
Figure 23. Germany Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. France Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. U.K. Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Italy Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Russia Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Ireland Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Asia-Pacific Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Alpha Particle Targeted Therapy Market Share by Region (2021–2032)
Figure 31. China Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Japan Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. South Korea Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Southeast Asia Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. India Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Australia & New Zealand Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Latin America Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Alpha Particle Targeted Therapy Market Share by Country (2021–2032)
Figure 39. Mexico Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Brazil Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Middle East & Africa Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Alpha Particle Targeted Therapy Market Share by Country (2021–2032)
Figure 43. Israel Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Saudi Arabia Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. UAE Alpha Particle Targeted Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Fusion Pharma Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2021–2026)
Figure 47. Bayer Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2021–2026)
Figure 48. Roche Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2021–2026)
Figure 49. Novartis Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2021–2026)
Figure 50. Orano Med Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2021–2026)
Figure 51. Oncoinvent AS Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2021–2026)
Figure 52. Perspective Therapeutics Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2021–2026)
Figure 53. Ablaze Pharma Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2021–2026)
Figure 54. ARTBIO Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2021–2026)
Figure 55. AstraZeneca Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2021–2026)
Figure 56. AdvanCell Revenue Growth Rate in Alpha Particle Targeted Therapy Business (2021–2026)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232